Literature DB >> 9838897

Central nervous system tumors: what have we learned and where are we heading?

E R Laws.   

Abstract

Molecular biology, laboratory and human studies, and clinical trials have furthered knowledge about the pathogenesis, behavior, and treatment of brain tumors. Technical advances such as functional imaging, computer-guided stereotactic surgical devices, and radiosurgery have improved treatment. The future promises continued progress, with the exploration of areas such as new chemotherapy delivery systems, gene therapy, boron capture therapy, and photodynamic therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9838897     DOI: 10.3322/canjclin.48.6.327

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  1 in total

1.  Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors.

Authors:  German G Gomez; Susana B Read; Lazaro E Gerschenson; Daniela Santoli; Adam Zweifach; Carol A Kruse
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.